Last reviewed · How we verify

NCT06844643: DPCASPA

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Recruiting now Last updated 13 April 2026
What this trial tests

trial in Axial Spondyloarthritis in 2,250 participants. Currently enrolling.

Timeline
1 March 2025
Primary endpoint
1 December 2030
1 December 2030

Quick facts

Lead sponsorChina-Japan Friendship Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment2,250
Start date1 March 2025
Primary completion1 December 2030
Estimated completion1 December 2030
Sites1 location across China

Conditions studied

Sponsor

China-Japan Friendship Hospital

Who can join

18 and older, any sex, with Axial Spondyloarthritis or Ankylosing Spondylitis (AS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Axial Spondyloarthritis

Currently open trials in the same condition.

Other China-Japan Friendship Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06844643.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing